Last updated: June 26, 2026, 4:50 am
RFMO-01: Rapid fire session from selected abstracts
Tracks
Room 520-AD
| Monday, August 31, 2026 |
| 11:00 AM - 12:30 PM |
Chairs & speakers
Dr Abdikarim Abdi
Exco, Treasurer, Congress Working Group
Yeditepe University
RFMO-0101 - Validation of a Basel Statements-Based Tool to Assess Hospital Pharmacy Preparedness Among Students in Türkiye
Dr Salwa Ahsan
Chief Pharmaceutical Officer
Shifa International Hospitals Ltd.
RFMO-0102 - Medicines availability during global geopolitical disruptions: A quaternary care hospital’s supply chain response in Pakistan
Prof Diane Ashiru-Oredope
UK Health Security Agency
RFMO-0103 - Pharmacist-led interventions for bacteraemia and antimicrobial-resistant bloodstream infections: a systematic scoping review
Ms Jane Booth
Deputy Director Of Pharmacy: Workforce
Monash Health
RFMO-0104 - Towards 2031: The evolution of a pharmacy workforce strategy
Dr Chongwei Wang
The First Affiliated Hospital Of Ustc, University Of Science And Technology Of China
RFMO-0105 - Early supratherapeutic tacrolimus exposure and infection risk after lung transplantation: Implications for therapeutic drug monitoring and pharmacist-led risk stratification
Prof Vincent Dagenais-Beaulé
University Of Ottawa
RFMO-0106 - Development and dissemination of a multi-agent psychotropic in-syringe compatibility chart for acute agitation
Ms Hua Ling Kao
Department Of Pharmacy, National Taiwan University Hospital Hsin-chu Branch Biomedical Park Hospital
RFMO-0107 - The efficacy and safety of micronutrient supplementation in adults during the acute phase of critical illness: A retrospective cohort study
Dr Navin Kumar Loganadan
Head Of Ambulatory Pharmacy Section
Hospital Putrajaya
RFMO-0108 - Pharmacist‑Led Diabetes Medication Therapy Adherence Clinic (DMTAC) for Asian Pediatric Type 1 Diabetes: Impact on Treatment Outcomes
Dr Holly Mansell
Professor
University Of Saskatchewan
RFMO-0109 - International Perspective of Pharmacist Role in Transplant
Mr Gi Kon Nam
University Of Sydney
RFMO-0110 - Global prevalence and factors associated with modified-release opioid use following orthopaedic surgery: Multinational retrospective cohort study
Prof Phuong Nguyen
Hai Phong University Of Medicine And Pharmacy
RFMO-0111 - How much vancomycin exposure is too much? AUC24 and the risk of acute kidney injury within 48 hours after therapeutic drug monitoring
Ms Ezinne V.C. Onwuekwe
Nova Scotia Health Authority
RFMO-0112 - Comparing Public AMR Surveillance Outputs in Canada and the WHO African Region: Implications for Pharmacist-Led Stewardship
Ms Lebogang Ramapuputla
Pharmacist
University Of Limpopo
RFMO-0113 - Medical practitioners' knowledge, prescribing practices, and compliance with attention-deficit/hyperactivity disorder treatment guidelines in Limpopo, South Africa
Dr Zaineb Saad
UNIVERSITY HASSAN II MOROCCO
RFMO-0114 - Empirical Antibiotic Therapy in Pediatric Intensive Care: Between Guideline Adherence and Stewardship Challenges
Ms Cam Anh Tran Phan
University of Bradford
RFMO-0115 - Safety of intravenous therapy in the home: A scoping review
Dr Chao Wang
Tianjin First Central Hospital，Nankai University
RFMO-0116 - The safety of proton pump inhibitors: An overview of systematic reviews and meta-analyses
